GLP-1 Drugs: A Prescription for Productivity?

GLP-1 drugs may offer substantial economic benefits by decreasing employee sick leave, according to a new study from the National Bureau of Economic Research. Patients using these medications, including Ozempic and Wegovy, experienced a 17% reduction in long-term sick leave, defined as absences exceeding 30 days. These drugs are known to improve patient health, notably by lowering the risk of cardiovascular events.

This reduction in sick days could lead to significant cost savings. The study estimates potential savings of up to 1.5% of an individual's salary, averaging around $866 per year. While Denmark's generous sick leave policies differ from the U.S., the findings suggest potential productivity gains. Reducing 'presenteeism'—working while sick—could make companies more productive and workers more effective.